Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004357:Drug Synergism; D005260:Female; D006719:Homovanillic Acid / Q000378:metabolism; D007099:Imipramine / Q000494:pharmacology; D009075:MSH Release-Inhibiting Hormone / Q000494:pharmacology*; D008297:Male; D051379:Mice; D018377:Neurotransmitter Agents / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
D018377:Neurotransmitter Agents; D013973:Thyrotropin-Releasing Hormone; D004295:Dihydroxyphenylalanine; D009075:MSH Release-Inhibiting Hormone; D010293:Pargyline; D007099:Imipramine; D006719:Homovanillic Acid